Nager syndrome: confirmation of SF3B4 haploinsufficiency as the major cause.

Nager syndrome belongs to the group of acrofacial dysostosis, which are characterized by the association of craniofacial and limb malformations. Recently, exome sequencing studies identified the SF3B4 gene as the cause of this condition in most patients. SF3B4 encodes a highly conserved protein implicated in mRNA splicing and bone morphogenic protein (BMP) signaling. We performed SF3B4 sequencing in 14 families (18 patients) whose features were suggestive of Nager syndrome and found nine mutations predicted to result in loss-of-function. SF3B4 is the major gene responsible for autosomal dominant Nager syndrome. All mutations reported predict null alleles, therefore precluding genotype-phenotype correlations. Most mutation-negative patients were phenotypically indistinguishable from patients with mutations, suggesting genetic heterogeneity.
AuthorsF Petit, F Escande, A S Jourdain, N Porchet, J Amiel, B Doray, M A Delrue, E Flori, C A Kim, S Marlin, S P Robertson, S Manouvrier-Hanu, M Holder-Espinasse
JournalClinical genetics (Clin Genet) Vol. 86 Issue 3 Pg. 246-51 (Sep 2014) ISSN: 1399-0004 [Electronic] Denmark
PMID24003905 (Publication Type: Journal Article)
Copyright© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Chemical References
  • RNA-Binding Proteins
  • SF3B4 protein, human
  • Base Sequence
  • Female
  • Genes, Dominant (genetics)
  • Genetic Predisposition to Disease (genetics)
  • Haploinsufficiency (genetics)
  • Humans
  • Male
  • Mandibulofacial Dysostosis (genetics, pathology)
  • Molecular Sequence Data
  • Mutation (genetics)
  • Phenotype
  • RNA-Binding Proteins (genetics)
  • Sequence Analysis, DNA

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: